On 30 March 2026, SF Holding released the 2025 work report of independent director Dr. Ding Yi, detailing board participation, committee activities and key supervisory focus areas for the year.
Dr. Ding Yi, PhD in Economics and an independent director since December 2022, confirmed that neither she nor her related parties hold positions or maintain relationships that could impair independence. The board completed a parallel assessment and reached the same conclusion.
Board and shareholder meetings • 9 board meetings: 3 attended on-site, 6 via telecommunication, zero absences or proxies. • 3 shareholder meetings: full attendance.
Committee engagement • Chair, Remuneration & Appraisal Committee (6 meetings). • Member, Audit Committee (8), Nomination Committee (3) and Strategy Committee (1). Dr. Ding participated in every session and voted in favour of all proposals.
Key matters reviewed 1. Remuneration & Incentives: confirmed 2024 executive pay, approved the 2025 compensation plan, oversaw the 2022 A-share stock-option adjustments and terminations, and supported the launch of an A-share “Co-Growth” employee share plan. 2. Financial Reporting & Audit: examined the 2024 annual report, 2025 quarterly and half-year results, internal-control self-assessments and PwC Zhongtian’s audit performance; endorsed the re-appointment of the external auditor for 2025. 3. Strategy & Budget: reviewed the 2025 strategic objectives, the 2024 sustainable-development report, the 2024 financial close and the 2025 budget. 4. Continuous Connected Transactions: verified that 2024 related-party dealings stayed within approved limits and complied with fair-value principles. 5. Senior Personnel: supported the re-election of the seventh board, and approved the appointments of the general manager, vice-general managers, chief financial officer and board secretary.
Field work and communication Dr. Ding completed 15 days of on-site duties, including inspections of Beijing transfer hubs and service outlets, and convened regular discussions with management on risk control, investor relations and public-opinion monitoring.
Investor-protection actions The report states that SF Holding’s disclosures—annual, interim and quarterly—were prepared and released in accordance with Shenzhen Stock Exchange and Hong Kong Stock Exchange rules. Dr. Ding also engaged minority shareholders through results briefings and shareholder meetings.
Dr. Ding plans to maintain rigorous oversight in 2026, prioritising board decision-making quality, risk management and the safeguarding of all shareholders’ rights.
Comments